Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Total Current Liabilities (2020 - 2024)

Intelligent Bio Solutions has reported Total Current Liabilities over the past 5 years, most recently at $5.7 million for Q1 2024.

  • Quarterly results put Total Current Liabilities at $5.7 million for Q1 2024, up 61.38% from a year ago — trailing twelve months through Mar 2024 was $5.7 million (up 61.38% YoY), and the annual figure for FY2023 was $5.9 million, up 26.18%.
  • Total Current Liabilities for Q1 2024 was $5.7 million at Intelligent Bio Solutions, up from $5.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for INBS hit a ceiling of $7.7 million in Q2 2020 and a floor of $1.2 million in Q4 2020.
  • Median Total Current Liabilities over the past 5 years was $4.4 million (2022), compared with a mean of $4.3 million.
  • Peak annual rise in Total Current Liabilities hit 243.73% in 2021, while the deepest fall reached 52.11% in 2021.
  • Intelligent Bio Solutions' Total Current Liabilities stood at $1.2 million in 2020, then skyrocketed by 243.73% to $4.0 million in 2021, then increased by 20.08% to $4.8 million in 2022, then grew by 7.65% to $5.2 million in 2023, then rose by 10.09% to $5.7 million in 2024.
  • The last three reported values for Total Current Liabilities were $5.7 million (Q1 2024), $5.2 million (Q4 2023), and $6.8 million (Q3 2023) per Business Quant data.